McKesson Corporation (MCK) Stock
MCK Key Statistics
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
CEO: Brian S. Tyler. Company website
MCK — Frequently Asked Questions
What is the MCK stock price today?
McKesson Corporation (MCK) trades at $1,079.79, down 0.26% on the day, as of Nov 12, 2026 09:21 UTC.
What is McKesson Corporation's market cap?
McKesson Corporation has a market capitalisation of $125.89B, calculated from the live MCK share price and shares outstanding.
What is the P/E ratio of MCK?
MCK trades at a trailing P/E of 27.77, from earnings per share of $38.88 over the last twelve months.
How much revenue does McKesson Corporation make?
McKesson Corporation generated revenue of $418.79B over the trailing twelve months, which puts the stock at 0.30 times sales.
Does MCK pay a dividend?
Yes. McKesson Corporation pays a dividend yielding 0.37% on the current share price.
What is the 52-week range for MCK?
MCK has traded between $723.68 and $1,121.50 over the past 52 weeks, and the last price is 3.7% below that high.
Is McKesson Corporation profitable?
Yes. McKesson Corporation keeps 1.12% of revenue as net income over the trailing twelve months.
What is the analyst price target for MCK?
Wall Street analysts rate MCK Buy, with an average price target of $998.57, 7.5% below the current price.
What sector is McKesson Corporation in?
McKesson Corporation is classified under the Healthcare sector and the Medical - Distribution industry, and is domiciled in US.
Who is the CEO of McKesson Corporation?
Brian S. Tyler is the chief executive of McKesson Corporation, which employs 42,300 people.
Where can I track MCK in real time?
QFI Terminal shows MCK with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See MCK live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open MCK in Terminal See plans